View of The influence of folate pathway polymorphisms on pemetrexed treatment outcome in patients with malignant mesothelioma

Return to Issue Details The influence of folate pathway polymorphisms on pemetrexed treatment outcome in patients with malignant mesothelioma Download Download PDF